Isordil Articles
NAACP attacks lack of BiDil Medicare coverage
5 February 2007
New Indian drug price cuts of 10%-70%
26 June 2006
FDA confirms no drugs equivalent to BiDil
15 May 2006
US minority coalition to aid pharma access
11 July 2005
US docs back Rx ethnic/racial group targeting
4 July 2005
NitroMed's BiDil closer to US FDA approval
27 June 2005
NitroMed's BiDil achieves Ph III goals
26 July 2004
Biovail in $130M rights deal with Wyeth
9 June 2003
Drugmakers warn over German generics move
17 June 2002
Schwarz Pharma net income up 65% as operating loss narrows
21 February 2001
NitroMed acquires BiDil NDA for CHF therapy
22 September 1999
Yamanouchi 1st Half Net Income Up 15%
14 November 1997
US Doctors "Unaware Of Year-Old Labeling Changes"
16 September 1996
Single-Digit Profits Growth For B-MS And W-L
5 August 1996
Sales Growth At Yamanouchi Led By Gaster
10 June 1996
Zeneca / Bayer: Sular agreement
22 January 1996
Yamanouchi Looks To New Products For Growth
23 October 1995
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
Outstanding 1st Qtr Performance For Astra
22 May 1995
AHCPR Guidelines On Heart Failure Management
27 February 1995
ITOROL LAUNCH IN JAPAN
25 July 1994
BOEH-MANNHEIM TO SELL MEDCO'S BIDIL
22 November 1993
FURTHER RESULTS FROM THE GISSI-3 STUDY
15 November 1993
RECORDATI REFOCUSES; NEW DRUGS OUT SOON
24 May 1993
US/CANADA DRUG PRICE STUDY "MISLEADING"
2 November 1992
FUJISAWA LAUNCHES HEART DRUG ANTUP
12 October 1992
ASTRA LAUNCH
5 October 1992
NITRATES: OLD DRUGS, BUT ONES WITH A FUTURE
20 April 1992
AGGRESSIVE MARKETING BOOSTS YAMANOUCHI
20 January 1992
ROBERTS TO ACQUIRE WYETH LABS DRUGS
6 January 1992
Showing 1-33 of 33 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
